Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy

Affiliations

¹ Department of Neuroradiology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
² Center for Movement Disorders, Parkinson-Klinik Ortenau, Wolfach, Germany.
³ Institute of Medical Biometry and Statistics, Section of Health Care Research and Rehabilitation Research, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Comment

Alexander Rau et al. Mov Disord. 2021 Sep.

. 2021 Sep;36(9):2207-2208.

doi: 10.1002/mds.28721.

¹ Department of Neuroradiology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
² Center for Movement Disorders, Parkinson-Klinik Ortenau, Wolfach, Germany.
³ Institute of Medical Biometry and Statistics, Section of Health Care Research and Rehabilitation Research, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.

No abstract available

Comment in

Reply to: "Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy".
Quattrone A, Antonini A, Vaillancourt DE, Seppi K, Ceravolo R, Strafella AP, Quattrone A. Quattrone A, et al. Mov Disord. 2021 Sep;36(9):2208-2209. doi: 10.1002/mds.28725. Mov Disord. 2021. PMID: 34543468 No abstract available.

A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study.
Quattrone A, Antonini A, Vaillancourt DE, Seppi K, Ceravolo R, Strafella AP, Morelli M, Nigro S, Vescio B, Bianco MG, Vasta R, Arcuri PP, Weis L, Fiorenzato E, Biundo R, Burciu RG, Krismer F, McFarland NR, Mueller C, Gizewski ER, Cosottini M, Del Prete E, Mazzucchi S, Quattrone A. Quattrone A, et al. Mov Disord. 2021 Mar;36(3):681-689. doi: 10.1002/mds.28364. Epub 2020 Nov 5. Mov Disord. 2021. PMID: 33151015 Free PMC article.

1. Quattrone A, Antonini A, Vaillancourt DE, et al. A new 4MRI measure to early differentiate progressive supranuclear palsy from de novo Parkinson's disease in clinical practice: an international study. Mov Disord 2021;36(3):681-689.
1. Hoglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria. Mov Disord 2017;32:853-864.
1. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
1. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015;30:1591-1601.